The Group Room
Advocacy and educational support provided in part by:
Dr. Stefan Gluck sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). They discuss personalized medicine as well as the need for more efficient tissue and biospecimen collection for cancer research. Stefan Gluck, MD is a Professor of Medicine, University of Miami, Associate Division [...]
Dr. Christopher Twelves sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). They discuss the results of the Phase III clinical trial comparing capecitabine (Xeloda) and eribulin (Halaven). The trial showed trends toward the superiority of eribulin in this setting but the results were [...]
Dr. Joanne Mortimer sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). They discuss research being conducted at the City Of Hope Cancer Center on the functional imaging of HER2-positive metastatic breast cancer. Joanne Mortimer, MD is the Vice Chair, Medical Oncology & Therapeutics [...]
Dr. Richard S. Finn sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). They discuss the combination of PD 0332991 and letrozole phase II clinical trial results. Richard S. Finn, MD is Associate Professor at the Jonsson Comprehensive Cancer Center at UCLA. Advocacy and [...]
Dr. Martine Piccart sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). They discuss how cancer patients and advocates can help lead the way for tissue and biospecimen collection for cancer research. Martine Piccart, MD, PhD is the current President of the European Society [...]
Dr. Martine Piccart sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). They discuss the results of a study she authored for patients with human epidermal growth factor receptor 2 (HER2)–positive early–stage breast cancer — one year of adjuvant trastuzumab (Herceptin) should remain the [...]
Dr. Edith Perez sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). They discuss her recent research with Anti-HER2 therapies presented at SABCS 2012. Edith A. Perez, MD is Deputy Director, Mayo Clinic Cancer Center — Group Vice Chair, Alliance for Clinical Trials in [...]
Dr. Larry Norton sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) for a three-part interview. This is the first in the three-part interview where he discusses the rapidly changing face of oncology and personalized medicine. Larry Norton, MD is the Deputy Physician-in-Chief for [...]
Dr. Larry Norton sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) for a three-part interview. This is the second in the three-part interview where he discusses the role of patients and advocates in the changing face of cancer care. Larry Norton, MD is [...]